Plaquenil and Pacing threshold increased - a phase IV clinical study of FDA data

Summary:

Pacing threshold increased is reported only by a few people who take Plaquenil.

The phase IV clinical study analyzes which people take Plaquenil and have Pacing threshold increased. It is created by eHealthMe based on reports of 80,685 people who have side effects while taking Plaquenil from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 26, 2023

80,685 people reported to have side effects when taking Plaquenil.
Among them, 1 person (0.0%) has Pacing threshold increased.

What is Plaquenil?

Plaquenil has active ingredients of hydroxychloroquine sulfate. It is often used in systemic lupus erythematosus. eHealthMe is studying from 83,267 Plaquenil users for its effectiveness, alternative drugs and more.

What is Pacing threshold increased?

Pacing threshold increased is found to be associated with 23 drugs and 8 conditions by eHealthMe.

Number of Plaquenil and Pacing threshold increased reports submitted per year:

Could Plaquenil cause Pacing threshold increased?

Gender of people who have Pacing threshold increased when taking Plaquenil *:

female: 100 %
male: 0.0 %

Age of people who have Pacing threshold increased when taking Plaquenil *:

Common drugs people take besides Plaquenil *:

Nabumetone: 1 person, 100.00%
Methotrexate: 1 person, 100.00%

Common side effects people have besides Pacing threshold increased *:

Cardiac Pacemaker Malfunction: 1 person, 100.00%
Atrioventricular Block Complete (heart block complete): 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Plaquenil and have Pacing threshold increased?

Check whether Pacing threshold increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Pacing threshold increased and when was it recovered:

Pacing threshold increased in Plaquenil

Expand to all the drugs that have ingredients of hydroxychloroquine sulfate:

Pacing threshold increased and drugs with ingredients of hydroxychloroquine sulfate (1 reports)

Alternative drugs to, pros and cons of Plaquenil:

Plaquenil (83,267 reports)

Common Plaquenil side effects:

Drug ineffective: 27,218 reports
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 18,054 reports
Pain: 13,999 reports
Joint pain: 12,296 reports
Joint swelling: 11,202 reports
Fatigue (feeling of tiredness): 11,129 reports
Rashes (redness): 9,134 reports
Headache (pain in head): 6,410 reports

Browse all side effects of Plaquenil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pacing threshold increased treatments and more:

Pacing threshold increased (16 reports)

COVID vaccines that are related to Pacing threshold increased:

All the drugs that are associated with Pacing threshold increased:

Pacing threshold increased (23 drugs)

All the conditions that are associated with Pacing threshold increased:

Pacing threshold increased (8 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydroxychloroquine sulfate (the active ingredients of Plaquenil) and Plaquenil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.